{"ticker": {"uuid": "fef373b5-80a0-4165-b299-994d5adb942b", "symbol": "REGN", "name": "Regeneron Pharmaceuticals, Inc.", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Lobbying Update: $630,000 of REGENERON PHARMACEUTICALS INC lobbying was just disclosed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZjZhN29ic21qZ09WVTBvZXZNTUptRE1YX0NpVVZaU1RSM1ZNS2FTSHJScVhVT3JYVXpOeXBhdXhla1V5S2gzWnVZdG1NVURkVnp1dGhqVEZnZ215MEhjb0VxcEtWcjRsRWdiRkhEVUVMX1pScjhlZVhST2FUMXAyMjJIcFlwVkY4YjJrclVIV08zTTNYLTI5dk5CUXF4Q2dNd2daTnhyMEQ0dWhTRHJaWEJ0X255Q0NpQmdlR25nSjB3Zk0?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-21T17:55:00+00:00", "published_display": "21 Jul 2026 17:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron\u2019s POTS Study Wraps Up: What REGN7544 Could Mean for REGN Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxPVndaNUNKTWttNU4xdzVORTUxQkRHZ2JoWU5EdjEzSlZhbDNkVFJ0c0h2elRieG1VemZnbUk5bGxjbWwtX2ZwVmk1ajFhQ2lLXzktdTNiVElBVVB0Z2FkOUFBMDNGOG82OFRsaEhkQlh1akpleDZYT2xLS1p4OXNRTmlnaUVWdDNrRkhEMmJqaDI3YURvckl3czM2TDY3eHN0eVJnbkxBTmdYSEFZejFsMGRtNFRpeFdQYTdQNUFsUE9FNEJRM25qNW4yM1VTcjZFUmI3LS1ORjNwc3RGUVNGWWFBYnQyVUhBUFQzOFFCNVdMckYyeUFNNTNjWW9SUzBGSnc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-21T16:37:43+00:00", "published_display": "21 Jul 2026 16:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgJBVV95cUxQYy0zZjVMV1E2R0IzajlMWnNJcnUtY3JVUVhaTUZMbnVPZmplbjlUZkNKM2tvdWpERHptV3llS0dyMXJjaVN5aVI0UUlSVndMWDdmRmQ2alYweHZ2ZzR5bEpnTlNRUEFERkRDZU83U1ZLMnhNSDlFbEdnV3REV1hHNXA1RzJsYkk0MTNlbTNfQS1WYmo2RExOaE13WDdOVmRpankxVDQ5RFpQSlk3ZERSSVV6ejE3d0NIQVhsS3dMallfWjZ2dGhEOEphelJ5SDQtSGxOMkk5d2tCT2F6Sk1TMVpyUXJTLXpnZ3FYVThHaDhfbUljNWdDci0xZjBwRU9qall6YTVYY2F1eFNqX3BlQnJqMHZiUm1YUEh1Skx5Rm44X0R5d3VzdVM0TWgyd05wOU5yazM3YUJiVlk0WlE?oc=5", "source_name": "PR Newswire", "published_at": "2026-07-21T14:07:00+00:00", "published_display": "21 Jul 2026 14:07", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron Pharmaceuticals Lawsuit Focuses on Trial Disclosures and REGN Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQNVBZdkk2TkY2VlhYM0dsVkNTcWV5eFZZNnFSZ19Ha2VscVJPOF9XNUZPT0Q3RUNRbVFWalhBZzMweFFuelJOZFFHT2ZZazhZZllNU3ZBeTBSYmQ1LU5mbE1nWUc3c0VfSGt6cmd1QzhVak13OGJtZHg4eVpDY1Q4czVlR2VuTUR1bDVkb3ZyMVFFQnF5WEo4Ry1XTThPSndrc3NydGVrQ19YRkZzZE9OUEdDLVN2eGtuZ1JFdHMyR0J0YWlv?oc=5", "source_name": "TipRanks", "published_at": "2026-07-20T20:32:59+00:00", "published_display": "20 Jul 2026 20:32", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REGENERNON PHARMACEUTICALS, INC. (REGN) INVESTOR ALERT", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wJBVV95cUxPOHBGVDh0b3l3R29HdElQU0R3QXJYV0JYVXNxMzBEcEtpanNtVmdfNjRlTk0yUlgzYVpSVGw5T3RrS2w2cGs5aXpmV0pKbk4zZ05MVTVvLXlJbUxFOWZTa0V5ZGtEbVRGN0ZQTEpaRFJCNkRPMnVDMEsyY2trWjFscFgxSnowemNjLW9KMWF4eEJodUhJbjB4UnpIVHc5dFVGRDB1aDJoNC1BZFBJLUptVUp3NDZMVzIzbkZvaW0zNGF1SE8tYWlEVEtRY3NOTWFMS2c1OVNVS3F1MndTeEQtRExlTnhJazMtT0E0VFZRbkxGN280Qm02RUhzSENNZ1hCelh1Z09OdzREc3BPWkowX192dEx3M0I2SlhpWVlfVklyNC05UkEzZGhKSFViOVhVOUFJVHljdERLZ3RiQkRGVGxZT1lpZFc5Y09GRnc5TkFzZEdfMHRhc1IwMDRjZUdrX0lZ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-07-20T18:42:53+00:00", "published_display": "20 Jul 2026 18:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron (REGN) Stock Looks Discounted As It Holds A 24% Gain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-17T17:27:53+00:00", "published_display": "17 Jul 2026 17:27", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron Pharmaceuticals (REGN) Rebounds As Undervalued View Holds, Is The Upside Already Priced In?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOYXpmaFI4ZTZmSjJTU3JXUmVCYUMzZnpXTGpsSDRDRWJyb3ZTOFZ3UVVGbE5lMkp6ci1Yc25KZGRTZXNhYVA1blhETkUzZFdwTEg3aDhuVVloV0I4enNYWTItdktoaU9QTER4WlFnblQ4YW5zeFhOYWpwcU16bkFIYU9DR3VULUhvdWhVLVBSclBTNl81Y2xObk11b1Ixa20yeHAtYm1YNzliQlVTUkhzS2xGOUNLYVU?oc=5", "source_name": "Market source", "published_at": "2026-07-17T14:10:54+00:00", "published_display": "17 Jul 2026 14:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron Pharmaceuticals (REGN) Stumbled In A Trial Setback, Is The Stock Still Cheap?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T12:55:14+00:00", "published_display": "15 Jul 2026 12:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disappointing Trial Results Hurt Regeneron Pharmaceuticals (REGN) in Q2", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNUUdRa1VqMWlHTjJaLTFwWmxMTUtPMW0tNG1aS1dGdlE3RUdXeUFwcFVZQzA0UXRiX3pWSnBDaU44eDh6cFVYMnJ5c0VRRGN5U3pDUVlGQXZENFhIUHMtc0ZYWnBOWW96eWFDbVkzbENLczlaZnhhMm1kUVR6NjhEempGNUtQaktPbDdnR3VIeVBXd1NBdXJyazlLNEJsWGRhdW9nLXNR?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQaGstaFdQa3pfYzJ1SFBhZ3ltbUxXS0IxVkhvc2xCTVFrdDU5dVVZaUZDZnpnNm85Y1NrVFhDc0xETEYzMkZNNmNzMHBDdTdvUDlQdklibFN4N2hwLTAySXVHUkRYcFJOWm55S3dwSERMWlNVTE1SVHAtWWVoZUYweHlvZ2IwM2FZQ1R5b3NmTFQwdUpuc09tZ0lTR0FDVWo1LVVB?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 19, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron Pharmaceuticals shares gain over 4% as technical momentum and upside gap attract buyers", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQcTB4Ums2UF9IcmtQWkZVWHIxZmxxMXVfb3BGc25LSFpXTkMyNlNwUEZxeXFCeUxpTGFrVkM0NmFTY0xUc2tQR0p2TDRlZEg3bFZpLXN3N3pEZmlBXzlkc0tXbUZWdWFlUHRWZmlMaFFfdWpGY2otVGhNTGtDQkQ5U3FnMmJfZ2c?oc=5", "source_name": "Traders Union", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron (REGN) Stock Looks Undervalued Even After A 20% Gain", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOSFAzZjROeDlMbllNcVBfbmIwMlpNUXdhU2dCaTZUa2VVODZZeW5UeDZHcW5HdFdzak00Xzk2RF95UnpfazM4N0NvY3FCTThCSVZqblJvenloN1BKRE1NcGNQenVzcnVZU2ZtclUwYjg3TEFncXI1OFdKSm40bFF3Z1JUa3NsaFBNTDlITGpXM1RnNTF5MDlJd0MtaWtnUl8xNWd0LXhB?oc=5", "source_name": "Market source", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron (REGN) Stock Looks Cheap On Earnings While Its 20% Gain Raises Questions", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals, Inc. (REGN) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPcEFMLXh0SlZzWkdHV1RaM3I5b2kxeF9Ub3k5XzNKSm1sd2JzaHhxemtmSFNucmkta2hfYVVzXzZxSGUtWkpJYUZmZHpTNWRqTzJHWE45dkpHZDk2N3lMcjlzcTdmZ0VmX0Q5Z3dSUlBmVlNrMmU1Y2MyamhUTkNCQjZPUHQwWWgxNGppcWVVS0xSbU5sUFFhZndhVXdLTmN4dW9n?oc=5", "source_name": "Market source", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buying pressure lifts Regeneron Pharmaceuticals stock higher in today's trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPQnVVeURPTXAwUzN2Nmt2QW5JRVpEUHVIYmsxdEdPV2llWFFnN3Y3V2RWZ0NSMlI0cWZwZV9ZQ280NTVBU2g5a196NVFzRy1ScFBHZmlCaWNRLVVwV3N6Ty05Y2xjZVNaMTZEWk1jcWNfUWx3OVpUYnZEejBZYmxfSzBnNlZad2MwVHZIUmRPVThfZ0RSeU9WODNtYw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNd1BMU1B1WmdmNnR1WGZOTjVhdWM4ODdKZWp4M21Ja0ZfVzlvMFhudmZoalVuTmRnNDBpanpkU1lBeFRyYU9QWURxaVhTZmJheDdvRFZiaGFEaHVXZE9aOURDdmFjaDVIYTI0WkRPSWxQbXVBeFo5M2hjaFFqU1hLdVVVQk1WTlJXQThXOEhKZHNfbVcxUmZTd0dVSW5QZVRKRHRWbUZRWQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Regeneron (REGN) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxONXV2V3Q5VUxkcXl0WUEtS2k3YWI0cklXLVhHcDhFbGRmQVY2Q0xqR2QzdFdPOG05NGR2amhDdzk3N1V1TnZIa0ltTkhGOVBPdHNpc0dicXMweV9HcnNza2M0VFZEeVJvcHpWZ2pRckJrdFVERTFKREQzNWl2ZUpwU09Ja3JUZ092Z1FGQTM5V1QtRWJBLWY0WEp6SFFpZw?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxPaElEUnNfMXZSWlNUNHpSQzItbUJjY3I3M3lSSXc1LV8zLWpjcWY0Xzl3WjBmZUp4RThrdDRDZnNMc3JFNTJ4QWpHZHd3ZlRIcHpqTDNlRUZNNldfcWRJQi1yOGltZl9qSFdwcUNJT2p1NmlVQWdmNmQ5RUhIY3g4NERESVdkaV9CSUFjYUNVeDFxaG1CYnJzNFpDanFDb0E2NUFYS1VWYTFVWlhIVWhJOU1ma1hhclNocERGdDJnRjl6dEhkbGdlM2NPa1IzZnc3VDFJbGpaZXdSUlpJNDFzN2hIajVLcUFVQVg1cVZjQjg0eWN3eUdKbGN4TzlaVnU1WEE?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Wall Street Analysts Predicting Regeneron Pharmaceuticals Stock Will Climb or Sink?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOeklDZm1TSWlCUXJiR240WUVXaGNETkF4QmQxZklXYWxHQmFudnpBMHVsem1BU0hCMzlQSzktZVNkajFpNlkxVUNrYU5lV1ZHbjdDckZiVG9TdVIxckpGcUlnMjJrWllPbkppVHZ5bUpMS3doMVRQYUctcFk1QWZsMVZGZ2R4VkZETzJyWU5TTXI5M0lmZkJEQjV4V0YyZEFwR09aekNIc2lvZw?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Regeneron Pharmaceuticals (REGN) Valuation After Melanoma Trial Setback And Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQclhicFMyX0JBSUk2ekZudEZlallXWGtnWlIybmx1MGpVLUJlZlFyTDBNY21fVVQxOGE0bzI3bnNoTUhLRDg2VXg4c19qV3k1WXp3XzlhVmFDeG1rUm1WNGQyQWFqamtpY3NrNHl0dDFld3ZEeTJINk9JemxSWjBrMjRieXVQU051Wl9KSWZfUWxjYXliTDFUVWMzd29fc0dMbHJuUTVuWDFUbVpOb2h3?oc=5", "source_name": "Market source", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron beats quarterly estimates on Dupixent demand; shares fall on Eylea weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNX015eVNYZjFJWDZ0ajR2elNwVkZmRmR3Q0V6ckNxZGRGXy1yb3dBT0tOWTV2SkxDbktKeXRMdnZGT3Q0Vnpiald4ZmQzNjhSaFg1THBycTB2SUJPRkladUxlZkpOd2RVMFpkekpybGFqbVEtUVZZVTdPQUd4Q3ZXVkVFQVJkQlIyNlpobWZkSFBRVjBMdTBxUWZEMEF2dXFkVmR4UW5zdGpGX2R5T0NvaHdaYmJQZVlIMHQxQmdYOEhhNlNGZTZuY0xXOG9aMjhxMUhNYw?oc=5", "source_name": "Reuters", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 38, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNYWptSHdpRjhGTll4aWRVa3FRcGxSaklOQ0dKRVJuN2FHTElkMEtCbXltNE1RbDRDTTB4VzVkWGJoWVNSV3l0RXJ1Wlo5RlotUFd6alZsVU55QkV3anRFZEp4YWlsd3VsTXlQV3U0eGxDRkFuTzA4N3Y1ZVBpQ1Q2Y2dPVktfbHFfdWxuRzdB?oc=5", "source_name": "Market source", "published_at": "2026-03-15T07:00:00+00:00", "published_display": "15 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron's experimental therapy combo effective in untreated cancer patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPR1ZQUHFiMnY1bG5EMFNYcmdrQlVFT1ZoMTk1NzYwLTBfZnNSUEZ4UTduOEc4cUdGbi03cTR6cnBsWGoydE5fRnhOcG5JMDB5SXJNaDBBOWFNLUNScU50dElyY1dUVE52aUN3YkJwbWQ2N3lfN3QtVzZkVk1CbFpYaGEwand6S3EyX2lUdlNzcXFfeGJ6NkVJT2ZCNXNJTkFuZEktWDhoNHpYd2J4QzJBSldITjBZNFJHcTlkZFJkRkhyOXNXM01VVkdIRmh3UVEwa0NPR2VBMDExUHY1Wmc?oc=5", "source_name": "Reuters", "published_at": "2025-12-06T08:00:00+00:00", "published_display": "06 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron tops quarterly estimates, plans to resubmit Eylea application", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOU0tlRHNwdS0ySDdVZFdRUERZX1NqaWNwMV91cFRCeFdfYWt1YnVyNTRnYzlyZWQtRnhzVlNFYlEwVW1ncVpXdERpWmh3aDdNMUFjdDBqNDIzRTdtZklRWmg5MXdHZjY4aW9QajVFd2JLcmVzX1laWGxBUFhuZ0s0d1R0aDVhMkx6UVZFZXFON2JqbHBDSVE3OXg1N1hmT1dldVAxQUxaTnVscm9LTFFrLTY4a05adUFSUVdqLVJWeWRzdmd0bWNoSzl3?oc=5", "source_name": "Reuters", "published_at": "2025-10-28T07:00:00+00:00", "published_display": "28 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US FDA declines to approve Regeneron's blood cancer therapy for second time", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUy1EeHRZaXYxUGFJU1VleGo4endSU0QwNk94QkRtOUcya2ItdzUzejVuSE5qQU9EbS01RHhoeVVOTUZ3WlJKWGl0dExhbnkwWWtYY21leEtIMUN5NmdBTG4wc3NKWlR1cVlWdUNUajBHOXNiSlE1Y013NmYySlByUDlVakRuSDYtTHB5THUzUTA1Yi16XzVNMmlGUE1td2xWYjRTYl94Ukl2UGtqSF8wSHdURmRLd3BuV0I4ZWllTVlsQ0M4aTBwZExmajJqOWVvOU9MUURR?oc=5", "source_name": "Reuters", "published_at": "2025-08-01T07:00:00+00:00", "published_display": "01 Aug 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron shares drop as higher-dose Eylea drug misses sales estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNUkdlemtmR0Z3dFBpMjF5MGdiYTNmZzI4SW1LcDNCdnQ4cV9Ra1BMMmQ1NG9wbGlNVExQNVMtZ3QwZFVwUHgxT0F0WWFFWUJuREdfcTRrZVdFeEVyZE9Iam4zVkpqRDFXOG1TMHExcm9GZXQ5WmhqWkZIeU9NS3BaQzJmZGw2SE13MGlBanFvUEFiZ2pidmotZldRd003TXZGa1BCV24xWlRjdHFiejZOeG9mMzJSSldaMWNENWlFcDhlMm9WSDR0Ymd4ZWJseHBCeWxUUg?oc=5", "source_name": "Reuters", "published_at": "2024-10-31T07:00:00+00:00", "published_display": "31 Oct 2024 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron beats quarterly results on strong demand for eczema, eye treatments", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQOGV2dVlIaXB0UXZNdktKbTJtc1dTLWpkMGVSakRTV3FfMHRZTFR1OHFlcWZBMzVNeV94SDZpQVpHaEdwLVlqd2Y0dVVpa2NrQUNCR3BWNVBKMFU0MGFtdjZ4bmg5Q2FoVHhYWVdQYlI5REdiZjZqY29aNFdNOUY4YXRFbGZ1cHhYQkxQU0RtTjBHc2VVbWhaUkhSa25ZNmtDUVVndFZGUFRqNF9kNGtxOFk4YjJEWkt2ZWFjblRWTVVwdWhvblNKVjRscnhvN3pFbDFaWlRNWWI?oc=5", "source_name": "Reuters", "published_at": "2024-08-01T07:00:00+00:00", "published_display": "01 Aug 2024 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US FDA declines to approve Regeneron's higher-dose Eylea, shares tumble", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNNzg0d01MeGtvTVp6VGZ0ZHZ2OGVudmQ0cl90T3JzSGxlWXBMbWtwX1NnXzY5UU43QlZXV2NGRlNRdVM3ZW1pU0ZtZE1wU3ZxdEwwQjVGblBsQTN2aEU1Q21vbXBmZkZoZXlTUTM2aURlVkp1QmJyUzFZRmRJelQyczBNSWd0VElKZjBNM21RRHVYR0FDeWVtaW1RZ3lEMm12VkFvU2dGOVkzVkFDUllEemItaFQ1N1o1eTVyTDJR?oc=5", "source_name": "Reuters", "published_at": "2023-06-27T07:00:00+00:00", "published_display": "27 Jun 2023 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Lobbying Update: $630,000 of REGENERON PHARMACEUTICALS INC lobbying was just disclosed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZjZhN29ic21qZ09WVTBvZXZNTUptRE1YX0NpVVZaU1RSM1ZNS2FTSHJScVhVT3JYVXpOeXBhdXhla1V5S2gzWnVZdG1NVURkVnp1dGhqVEZnZ215MEhjb0VxcEtWcjRsRWdiRkhEVUVMX1pScjhlZVhST2FUMXAyMjJIcFlwVkY4YjJrclVIV08zTTNYLTI5dk5CUXF4Q2dNd2daTnhyMEQ0dWhTRHJaWEJ0X255Q0NpQmdlR25nSjB3Zk0?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-21T17:55:00+00:00", "published_display": "21 Jul 2026 17:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron\u2019s POTS Study Wraps Up: What REGN7544 Could Mean for REGN Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxPVndaNUNKTWttNU4xdzVORTUxQkRHZ2JoWU5EdjEzSlZhbDNkVFJ0c0h2elRieG1VemZnbUk5bGxjbWwtX2ZwVmk1ajFhQ2lLXzktdTNiVElBVVB0Z2FkOUFBMDNGOG82OFRsaEhkQlh1akpleDZYT2xLS1p4OXNRTmlnaUVWdDNrRkhEMmJqaDI3YURvckl3czM2TDY3eHN0eVJnbkxBTmdYSEFZejFsMGRtNFRpeFdQYTdQNUFsUE9FNEJRM25qNW4yM1VTcjZFUmI3LS1ORjNwc3RGUVNGWWFBYnQyVUhBUFQzOFFCNVdMckYyeUFNNTNjWW9SUzBGSnc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-21T16:37:43+00:00", "published_display": "21 Jul 2026 16:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgJBVV95cUxQYy0zZjVMV1E2R0IzajlMWnNJcnUtY3JVUVhaTUZMbnVPZmplbjlUZkNKM2tvdWpERHptV3llS0dyMXJjaVN5aVI0UUlSVndMWDdmRmQ2alYweHZ2ZzR5bEpnTlNRUEFERkRDZU83U1ZLMnhNSDlFbEdnV3REV1hHNXA1RzJsYkk0MTNlbTNfQS1WYmo2RExOaE13WDdOVmRpankxVDQ5RFpQSlk3ZERSSVV6ejE3d0NIQVhsS3dMallfWjZ2dGhEOEphelJ5SDQtSGxOMkk5d2tCT2F6Sk1TMVpyUXJTLXpnZ3FYVThHaDhfbUljNWdDci0xZjBwRU9qall6YTVYY2F1eFNqX3BlQnJqMHZiUm1YUEh1Skx5Rm44X0R5d3VzdVM0TWgyd05wOU5yazM3YUJiVlk0WlE?oc=5", "source_name": "PR Newswire", "published_at": "2026-07-21T14:07:00+00:00", "published_display": "21 Jul 2026 14:07", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron Pharmaceuticals Lawsuit Focuses on Trial Disclosures and REGN Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQNVBZdkk2TkY2VlhYM0dsVkNTcWV5eFZZNnFSZ19Ha2VscVJPOF9XNUZPT0Q3RUNRbVFWalhBZzMweFFuelJOZFFHT2ZZazhZZllNU3ZBeTBSYmQ1LU5mbE1nWUc3c0VfSGt6cmd1QzhVak13OGJtZHg4eVpDY1Q4czVlR2VuTUR1bDVkb3ZyMVFFQnF5WEo4Ry1XTThPSndrc3NydGVrQ19YRkZzZE9OUEdDLVN2eGtuZ1JFdHMyR0J0YWlv?oc=5", "source_name": "TipRanks", "published_at": "2026-07-20T20:32:59+00:00", "published_display": "20 Jul 2026 20:32", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REGENERNON PHARMACEUTICALS, INC. (REGN) INVESTOR ALERT", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wJBVV95cUxPOHBGVDh0b3l3R29HdElQU0R3QXJYV0JYVXNxMzBEcEtpanNtVmdfNjRlTk0yUlgzYVpSVGw5T3RrS2w2cGs5aXpmV0pKbk4zZ05MVTVvLXlJbUxFOWZTa0V5ZGtEbVRGN0ZQTEpaRFJCNkRPMnVDMEsyY2trWjFscFgxSnowemNjLW9KMWF4eEJodUhJbjB4UnpIVHc5dFVGRDB1aDJoNC1BZFBJLUptVUp3NDZMVzIzbkZvaW0zNGF1SE8tYWlEVEtRY3NOTWFMS2c1OVNVS3F1MndTeEQtRExlTnhJazMtT0E0VFZRbkxGN280Qm02RUhzSENNZ1hCelh1Z09OdzREc3BPWkowX192dEx3M0I2SlhpWVlfVklyNC05UkEzZGhKSFViOVhVOUFJVHljdERLZ3RiQkRGVGxZT1lpZFc5Y09GRnc5TkFzZEdfMHRhc1IwMDRjZUdrX0lZ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-07-20T18:42:53+00:00", "published_display": "20 Jul 2026 18:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron (REGN) Stock Looks Discounted As It Holds A 24% Gain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-17T17:27:53+00:00", "published_display": "17 Jul 2026 17:27", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron Pharmaceuticals (REGN) Rebounds As Undervalued View Holds, Is The Upside Already Priced In?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOYXpmaFI4ZTZmSjJTU3JXUmVCYUMzZnpXTGpsSDRDRWJyb3ZTOFZ3UVVGbE5lMkp6ci1Yc25KZGRTZXNhYVA1blhETkUzZFdwTEg3aDhuVVloV0I4enNYWTItdktoaU9QTER4WlFnblQ4YW5zeFhOYWpwcU16bkFIYU9DR3VULUhvdWhVLVBSclBTNl81Y2xObk11b1Ixa20yeHAtYm1YNzliQlVTUkhzS2xGOUNLYVU?oc=5", "source_name": "Market source", "published_at": "2026-07-17T14:10:54+00:00", "published_display": "17 Jul 2026 14:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron Pharmaceuticals (REGN) Stumbled In A Trial Setback, Is The Stock Still Cheap?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T12:55:14+00:00", "published_display": "15 Jul 2026 12:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disappointing Trial Results Hurt Regeneron Pharmaceuticals (REGN) in Q2", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNUUdRa1VqMWlHTjJaLTFwWmxMTUtPMW0tNG1aS1dGdlE3RUdXeUFwcFVZQzA0UXRiX3pWSnBDaU44eDh6cFVYMnJ5c0VRRGN5U3pDUVlGQXZENFhIUHMtc0ZYWnBOWW96eWFDbVkzbENLczlaZnhhMm1kUVR6NjhEempGNUtQaktPbDdnR3VIeVBXd1NBdXJyazlLNEJsWGRhdW9nLXNR?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQaGstaFdQa3pfYzJ1SFBhZ3ltbUxXS0IxVkhvc2xCTVFrdDU5dVVZaUZDZnpnNm85Y1NrVFhDc0xETEYzMkZNNmNzMHBDdTdvUDlQdklibFN4N2hwLTAySXVHUkRYcFJOWm55S3dwSERMWlNVTE1SVHAtWWVoZUYweHlvZ2IwM2FZQ1R5b3NmTFQwdUpuc09tZ0lTR0FDVWo1LVVB?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 19, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron Pharmaceuticals shares gain over 4% as technical momentum and upside gap attract buyers", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQcTB4Ums2UF9IcmtQWkZVWHIxZmxxMXVfb3BGc25LSFpXTkMyNlNwUEZxeXFCeUxpTGFrVkM0NmFTY0xUc2tQR0p2TDRlZEg3bFZpLXN3N3pEZmlBXzlkc0tXbUZWdWFlUHRWZmlMaFFfdWpGY2otVGhNTGtDQkQ5U3FnMmJfZ2c?oc=5", "source_name": "Traders Union", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron (REGN) Stock Looks Undervalued Even After A 20% Gain", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOSFAzZjROeDlMbllNcVBfbmIwMlpNUXdhU2dCaTZUa2VVODZZeW5UeDZHcW5HdFdzak00Xzk2RF95UnpfazM4N0NvY3FCTThCSVZqblJvenloN1BKRE1NcGNQenVzcnVZU2ZtclUwYjg3TEFncXI1OFdKSm40bFF3Z1JUa3NsaFBNTDlITGpXM1RnNTF5MDlJd0MtaWtnUl8xNWd0LXhB?oc=5", "source_name": "Market source", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron (REGN) Stock Looks Cheap On Earnings While Its 20% Gain Raises Questions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxONGZ0anNDVlFFeTBlSjVhaFhkV3lIdElEZzhSVTlOb2N1aXlEaEZQdVpvMnM2WFNzWFE4dV9FOGxQZWZpQnVWMEdWcWM3Y3FRMXRDNU5OanhTLUZNUUdCZXdLLXloTDJYSG5zXzJwR0JLY2k3Z3NsbkN2Wm4wdWY2UktsTmstVmdadHEteDdSV0tOUEwtOVljY1BYQkVQOFN2ZDhrdmZ1RkE2N0hQVFhuNzVwMnlUMC12T0s4S1BRWnZtNDhkTEdfNWVxUlQ1WlpkNmFLaXNidVFoMmRiYXVWenk5QlVkSmVqVWNwdkh5UmLSAfYBQVVfeXFMUExKem9FUk5lNnRnTG9Lb1MxYWxZd2ctUkdtYkxTSFhDVWR5TjJNSkFnbXFWNXd5a3RLeUdrVC1ZdWFiOVlsVkprb2tKVkNsM3JXaV91clBhMGhLMFQ3THlpOGktVExoNmtrNmY5cGd2eldmR2Q3MUFqeVBvOU91Yk1ONHZ1RUV3X05JMkl6a01YSHhIRkRXNmk1UVI0MjVzOERiTW5sZV9aaENZUW9HbHA3U2x5aGJtWEFxdUxUUDg0dWxhSE1rMGlONklYb0UtaWNvRTVrUUdkTmFodHhITm9ZbWhQbmgxMVRHa2NjZ2ItSGk4MXRR?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals, Inc. (REGN) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPcEFMLXh0SlZzWkdHV1RaM3I5b2kxeF9Ub3k5XzNKSm1sd2JzaHhxemtmSFNucmkta2hfYVVzXzZxSGUtWkpJYUZmZHpTNWRqTzJHWE45dkpHZDk2N3lMcjlzcTdmZ0VmX0Q5Z3dSUlBmVlNrMmU1Y2MyamhUTkNCQjZPUHQwWWgxNGppcWVVS0xSbU5sUFFhZndhVXdLTmN4dW9n?oc=5", "source_name": "Market source", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buying pressure lifts Regeneron Pharmaceuticals stock higher in today's trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPQnVVeURPTXAwUzN2Nmt2QW5JRVpEUHVIYmsxdEdPV2llWFFnN3Y3V2RWZ0NSMlI0cWZwZV9ZQ280NTVBU2g5a196NVFzRy1ScFBHZmlCaWNRLVVwV3N6Ty05Y2xjZVNaMTZEWk1jcWNfUWx3OVpUYnZEejBZYmxfSzBnNlZad2MwVHZIUmRPVThfZ0RSeU9WODNtYw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNd1BMU1B1WmdmNnR1WGZOTjVhdWM4ODdKZWp4M21Ja0ZfVzlvMFhudmZoalVuTmRnNDBpanpkU1lBeFRyYU9QWURxaVhTZmJheDdvRFZiaGFEaHVXZE9aOURDdmFjaDVIYTI0WkRPSWxQbXVBeFo5M2hjaFFqU1hLdVVVQk1WTlJXQThXOEhKZHNfbVcxUmZTd0dVSW5QZVRKRHRWbUZRWQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Regeneron (REGN) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxONXV2V3Q5VUxkcXl0WUEtS2k3YWI0cklXLVhHcDhFbGRmQVY2Q0xqR2QzdFdPOG05NGR2amhDdzk3N1V1TnZIa0ltTkhGOVBPdHNpc0dicXMweV9HcnNza2M0VFZEeVJvcHpWZ2pRckJrdFVERTFKREQzNWl2ZUpwU09Ja3JUZ092Z1FGQTM5V1QtRWJBLWY0WEp6SFFpZw?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxPaElEUnNfMXZSWlNUNHpSQzItbUJjY3I3M3lSSXc1LV8zLWpjcWY0Xzl3WjBmZUp4RThrdDRDZnNMc3JFNTJ4QWpHZHd3ZlRIcHpqTDNlRUZNNldfcWRJQi1yOGltZl9qSFdwcUNJT2p1NmlVQWdmNmQ5RUhIY3g4NERESVdkaV9CSUFjYUNVeDFxaG1CYnJzNFpDanFDb0E2NUFYS1VWYTFVWlhIVWhJOU1ma1hhclNocERGdDJnRjl6dEhkbGdlM2NPa1IzZnc3VDFJbGpaZXdSUlpJNDFzN2hIajVLcUFVQVg1cVZjQjg0eWN3eUdKbGN4TzlaVnU1WEE?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Wall Street Analysts Predicting Regeneron Pharmaceuticals Stock Will Climb or Sink?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOeklDZm1TSWlCUXJiR240WUVXaGNETkF4QmQxZklXYWxHQmFudnpBMHVsem1BU0hCMzlQSzktZVNkajFpNlkxVUNrYU5lV1ZHbjdDckZiVG9TdVIxckpGcUlnMjJrWllPbkppVHZ5bUpMS3doMVRQYUctcFk1QWZsMVZGZ2R4VkZETzJyWU5TTXI5M0lmZkJEQjV4V0YyZEFwR09aekNIc2lvZw?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Regeneron Pharmaceuticals (REGN) Valuation After Melanoma Trial Setback And Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQclhicFMyX0JBSUk2ekZudEZlallXWGtnWlIybmx1MGpVLUJlZlFyTDBNY21fVVQxOGE0bzI3bnNoTUhLRDg2VXg4c19qV3k1WXp3XzlhVmFDeG1rUm1WNGQyQWFqamtpY3NrNHl0dDFld3ZEeTJINk9JemxSWjBrMjRieXVQU051Wl9KSWZfUWxjYXliTDFUVWMzd29fc0dMbHJuUTVuWDFUbVpOb2h3?oc=5", "source_name": "Market source", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron beats quarterly estimates on Dupixent demand; shares fall on Eylea weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNX015eVNYZjFJWDZ0ajR2elNwVkZmRmR3Q0V6ckNxZGRGXy1yb3dBT0tOWTV2SkxDbktKeXRMdnZGT3Q0Vnpiald4ZmQzNjhSaFg1THBycTB2SUJPRkladUxlZkpOd2RVMFpkekpybGFqbVEtUVZZVTdPQUd4Q3ZXVkVFQVJkQlIyNlpobWZkSFBRVjBMdTBxUWZEMEF2dXFkVmR4UW5zdGpGX2R5T0NvaHdaYmJQZVlIMHQxQmdYOEhhNlNGZTZuY0xXOG9aMjhxMUhNYw?oc=5", "source_name": "Reuters", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 38, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNYWptSHdpRjhGTll4aWRVa3FRcGxSaklOQ0dKRVJuN2FHTElkMEtCbXltNE1RbDRDTTB4VzVkWGJoWVNSV3l0RXJ1Wlo5RlotUFd6alZsVU55QkV3anRFZEp4YWlsd3VsTXlQV3U0eGxDRkFuTzA4N3Y1ZVBpQ1Q2Y2dPVktfbHFfdWxuRzdB?oc=5", "source_name": "Market source", "published_at": "2026-03-15T07:00:00+00:00", "published_display": "15 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron's experimental therapy combo effective in untreated cancer patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPR1ZQUHFiMnY1bG5EMFNYcmdrQlVFT1ZoMTk1NzYwLTBfZnNSUEZ4UTduOEc4cUdGbi03cTR6cnBsWGoydE5fRnhOcG5JMDB5SXJNaDBBOWFNLUNScU50dElyY1dUVE52aUN3YkJwbWQ2N3lfN3QtVzZkVk1CbFpYaGEwand6S3EyX2lUdlNzcXFfeGJ6NkVJT2ZCNXNJTkFuZEktWDhoNHpYd2J4QzJBSldITjBZNFJHcTlkZFJkRkhyOXNXM01VVkdIRmh3UVEwa0NPR2VBMDExUHY1Wmc?oc=5", "source_name": "Reuters", "published_at": "2025-12-06T08:00:00+00:00", "published_display": "06 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron tops quarterly estimates, plans to resubmit Eylea application", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOU0tlRHNwdS0ySDdVZFdRUERZX1NqaWNwMV91cFRCeFdfYWt1YnVyNTRnYzlyZWQtRnhzVlNFYlEwVW1ncVpXdERpWmh3aDdNMUFjdDBqNDIzRTdtZklRWmg5MXdHZjY4aW9QajVFd2JLcmVzX1laWGxBUFhuZ0s0d1R0aDVhMkx6UVZFZXFON2JqbHBDSVE3OXg1N1hmT1dldVAxQUxaTnVscm9LTFFrLTY4a05adUFSUVdqLVJWeWRzdmd0bWNoSzl3?oc=5", "source_name": "Reuters", "published_at": "2025-10-28T07:00:00+00:00", "published_display": "28 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US FDA declines to approve Regeneron's blood cancer therapy for second time", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUy1EeHRZaXYxUGFJU1VleGo4endSU0QwNk94QkRtOUcya2ItdzUzejVuSE5qQU9EbS01RHhoeVVOTUZ3WlJKWGl0dExhbnkwWWtYY21leEtIMUN5NmdBTG4wc3NKWlR1cVlWdUNUajBHOXNiSlE1Y013NmYySlByUDlVakRuSDYtTHB5THUzUTA1Yi16XzVNMmlGUE1td2xWYjRTYl94Ukl2UGtqSF8wSHdURmRLd3BuV0I4ZWllTVlsQ0M4aTBwZExmajJqOWVvOU9MUURR?oc=5", "source_name": "Reuters", "published_at": "2025-08-01T07:00:00+00:00", "published_display": "01 Aug 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron shares drop as higher-dose Eylea drug misses sales estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNUkdlemtmR0Z3dFBpMjF5MGdiYTNmZzI4SW1LcDNCdnQ4cV9Ra1BMMmQ1NG9wbGlNVExQNVMtZ3QwZFVwUHgxT0F0WWFFWUJuREdfcTRrZVdFeEVyZE9Iam4zVkpqRDFXOG1TMHExcm9GZXQ5WmhqWkZIeU9NS3BaQzJmZGw2SE13MGlBanFvUEFiZ2pidmotZldRd003TXZGa1BCV24xWlRjdHFiejZOeG9mMzJSSldaMWNENWlFcDhlMm9WSDR0Ymd4ZWJseHBCeWxUUg?oc=5", "source_name": "Reuters", "published_at": "2024-10-31T07:00:00+00:00", "published_display": "31 Oct 2024 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron beats quarterly results on strong demand for eczema, eye treatments", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQOGV2dVlIaXB0UXZNdktKbTJtc1dTLWpkMGVSakRTV3FfMHRZTFR1OHFlcWZBMzVNeV94SDZpQVpHaEdwLVlqd2Y0dVVpa2NrQUNCR3BWNVBKMFU0MGFtdjZ4bmg5Q2FoVHhYWVdQYlI5REdiZjZqY29aNFdNOUY4YXRFbGZ1cHhYQkxQU0RtTjBHc2VVbWhaUkhSa25ZNmtDUVVndFZGUFRqNF9kNGtxOFk4YjJEWkt2ZWFjblRWTVVwdWhvblNKVjRscnhvN3pFbDFaWlRNWWI?oc=5", "source_name": "Reuters", "published_at": "2024-08-01T07:00:00+00:00", "published_display": "01 Aug 2024 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US FDA declines to approve Regeneron's higher-dose Eylea, shares tumble", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNNzg0d01MeGtvTVp6VGZ0ZHZ2OGVudmQ0cl90T3JzSGxlWXBMbWtwX1NnXzY5UU43QlZXV2NGRlNRdVM3ZW1pU0ZtZE1wU3ZxdEwwQjVGblBsQTN2aEU1Q21vbXBmZkZoZXlTUTM2aURlVkp1QmJyUzFZRmRJelQyczBNSWd0VElKZjBNM21RRHVYR0FDeWVtaW1RZ3lEMm12VkFvU2dGOVkzVkFDUllEemItaFQ1N1o1eTVyTDJR?oc=5", "source_name": "Reuters", "published_at": "2023-06-27T07:00:00+00:00", "published_display": "27 Jun 2023 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 90, "total_relevant": 29, "sentiment_summary": {"positive": 10, "negative": 8, "neutral": 11, "score": 51, "total": 29, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 13.3, "count": 21}, {"event": "earnings", "label": "Earnings", "weight": 2.55, "count": 4}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.9, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 10835.99, "latest_week": "2026-07-17", "one_week_move": 0.0, "four_week_move": 3.0, "twelve_week_move": -16.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.058757, "market_dynamics_buy_signal": false, "relative_strength": -12.466716, "fair_value_gap": -24.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.0752, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +3.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 51, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 11}, {"label": "Reuters", "count": 7}, {"label": "simplywall.st", "count": 3}, {"label": "TipRanks", "count": 2}, {"label": "PR Newswire", "count": 2}, {"label": "Traders Union", "count": 2}, {"label": "Quiver Quantitative", "count": 1}, {"label": "GlobeNewswire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 29}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 21}, {"label": "Earnings", "count": 4}, {"label": "Regulatory and legal", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "29", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "7", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, +3.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Lobbying Update: $630,000 of REGENERON PHARMACEUTICALS INC lobbying was just disclosed"}], "updated_at": "2026-07-21T19:36:16.798431+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}